Value of Glycemic Indices for Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Retrospective

Matthias Manfred Deininger1, Miriam Weiss2,3, Stephanie Wied4

  • 1Department of Intensive and Intermediate Care, Medical Faculty, RWTH Aachen University, 52074 Aachen, Germany.

Brain Sciences
|September 28, 2024
PubMed

Insights

Elevated blood glucose levels, including time-weighted average glucose and a novel dysglycemic rate, were significantly higher in aneurysmal subarachnoid hemorrhage patients who developed delayed cerebral ischemia. These glucose indices may help identify at-risk patients and aid in early DCI detection.

Area of Science:

  • Neurology
  • Critical Care Medicine
  • Endocrinology

Background:

  • Delayed cerebral ischemia (DCI) is a serious complication of aneurysmal subarachnoid hemorrhage (aSAH), leading to poor outcomes.
  • Early DCI detection is challenging but critical for patient management.
  • Blood glucose dysregulation is common after aSAH and may contribute to DCI development.

Purpose of the Study:

  • To investigate the association between glucose indices and DCI in aSAH patients.
  • To determine if glycemic parameters can identify patients at risk for DCI.
  • To assess the utility of glucose indices for improving DCI detection.

Main Methods:

  • Retrospective observational study of 151 aSAH patients (2016-2019).
  • Analysis of glycemic indices, including time-weighted average glucose (TWAG) and time-unified dysglycemic rate (TUDR140), before and after DCI onset.
  • Comparison of glucose indices between patients who developed DCI and those who did not.

Main Results:

  • Patients who developed DCI had significantly higher TWAG, mean blood glucose, and TUDR140 in the pre-DCI period compared to the no-DCI group.
  • Significant increases in TWAG and TUDR140 were observed at the onset of DCI.
  • Elevated blood glucose levels were present before DCI and increased further at its onset.

Conclusions:

  • DCI patients exhibit altered blood glucose profiles, with elevated levels preceding and peaking at DCI onset.
  • Glucose indices show potential as biomarkers for identifying DCI risk and facilitating earlier detection.
  • Further prospective studies are required to validate these findings and explore their clinical application in multiparametric models.